MEHRA UNEEK (Chief Financial Officer) reported 1 transaction at BRIDGEBIO ONCOLOGY THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 5/5/2026ACC: 0001193125-26-207031
Officer· Chief Financial Officer
Since Mar 2026
-524.00
Net shares
Net seller
$4.7K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
524.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−524.00
Price / share
$9.03
Trade value
$4.73K
% of position
2.2%
4/1/2026
23.33K→22.81K
Total
Net shares
−524.00
Net value
-$4.73K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/1/2026 | F · Tax Withholding | −524.00 | $9.03 | $4.73K | 2.2% | 23.33K | 22.81K |
| Total | −524.00 | -$4.73K | ||||||
Derivative Transactions0
No derivative transactions reported